Position in BNTX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$16,917,884
+$2,788,631 QoQ
Shares Held
181,815
+14.4% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#50
of 282 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. BNTX ranks #15 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in BNTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,917,884 | 181,815 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $14,129,253 | 158,970 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $16,105,745 | 169,178 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $16,572,203 | 168,041 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $18,503,953 | 173,795 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,042,819 | 11,452 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $5,011,748 | 43,982 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,242,507 | 44,140 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $609,932 | 7,590 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $660,048 | 7,155 | Shares | Sole | 2024-05-08 | |
| 2022-12-31 | $7,629,072 | 50,786 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $11,170,896 | 82,821 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $12,022,827 | 80,636 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $17,884,751 | 104,859 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $26,594,132 | 103,158 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $21,675,406 | 79,400 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $32,855,509 | 146,755 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $13,208,823 | 120,971 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,162,754 | 87,865 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,068,300 | 58,765 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,061,166 | 15,900 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||